相关实验视频
Updated: May 20, 2025
08:43
Investigating Intestinal Inflammation in DSS-induced Model of IBD
Published on: February 1, 2012
67.0K
从较新的天生的免疫系统生物标志物的角度看炎症性肠病
Martin Tobi1, Fadi Antaki1, MaryAnn Rambus1
1Department of Research and Development, Detroit John D. Dingle VAMC, Detroit, MI 48201, USA.
Gastrointestinal disorders (Basel, Switzerland)
|March 25, 2025
概括
炎症性肠病 (IBD) 亚型,性结肠炎 (UC) 和克罗恩病 (CD) 具有相似的先天免疫系统 (InImS) 概况. 研究人员发现UC和CD患者之间的FERAD比率没有显著差异,这表明IBD的统一免疫基础.
科学领域:
- 免疫学 免疫学 免疫学
- 胃肠病学 胃肠病学
- 在瘤学瘤学.
背景情况:
- 炎症性肠病 (IBD) 的理解已经进化,认识到性结肠炎 (UC) 和克罗恩病 (CD) 之间的共享致病性.
- 天生的免疫系统 (InImS) 正在成为IBD的一个关键因素,增强对其免疫基础的理解.
研究的目的:
- 调查UC和CD之间的先天性免疫系统 (InImS) 标志物的相似性.
- 评估FERAD比率作为IBD患者InImS的衡量标准.
主要方法:
- 预期招募2185名患有结直肠癌高风险的患者,包括31名UC和18名CD患者,以及2136名对照人群.
- 使用费里/便p87比率 (FERAD),结肠镜排泄物 (FEREFF) 和中性粒细胞与淋巴细胞比率 (NLR) 作为InImS的测量.
- 评估p87组织免疫组织化学 (IHC) 和其他InImS标志物.
主要成果:
- 在UC和CD患者之间的FERAD比率中没有发现显著差异.
- 在IBD实体和对照组之间发现了FERAD比率的实质差异.
- 绝对中性粒细胞/淋巴细胞比率也与UC和CD相一致.
结论:
- 在克罗恩病 (CD) 和性结肠炎 (UC) 两种疾病中,先天性免疫系统 (InImS) 概况相似.
- 共享的p87表达和其他InImS标志物支持UC和CD病原体的融合.
- 费拉德比率是评估IBD中的InImS的一个方便和有效的措施.
相关概念视频
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
288
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
288
01:30Inflammatory Bowel Disease II: Crohn's Disease
141
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
141
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
103
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
103
01:29Inflammatory Bowel Disease IV: Pharmacological Management
83
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
83
01:17Chronic Bowel Disorders: Introduction
374
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
374
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
106
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
106